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SHORT REPORT
Importance of ICD-10 coding directive 
change for acute gastroenteritis (unspecified) 
for rotavirus vaccine impact studies: illustration 
from a population-based cohort study 
from Ontario, Canada
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Abstract 
Background: In Ontario, Canada, we conducted an evaluation of rotavirus (RV) vaccine on hospitalizations and 
Emergency Department (ED) visitations for acute gastroenteritis (AGE). In our original analysis, any one of the Interna-
tional Classification of Disease, Version 10 (ICD-10) codes was used for outcome ascertainment: RV-specific- (A08.0), 
viral- (A08.3, A08. 4, A08.5), and unspecified infectious- gastroenteritis (A09). Annual age-specific rates per 10,000 
population were calculated.
Findings: The average monthly rate of AGE hospitalization for children under age two increased from 0.82 per 10,000 
from January 2003 to March 2009, to 2.35 over the period of April 2009 to March 31, 2013. Similar trends were found 
for ED consultations and in other age groups. A rise in events corresponding to the A09 code was found when the 
outcome definition was disaggregated by ICD-10 code. Documentation obtained from the World Health Organization 
confirmed that a change in directive for the classification of unspecified gastroenteritis occurred with the release of 
ICD-10 in April 2009. AGE events previously classified under the code K52.9, are now classified under code A09.9.
Conclusions: Based on change in the classification of unspecified gastroenteritis we modified our outcome defini-
tion to also include unspecified non-infectious-gastroenteritis (K52.9). We recommend other investigators consider 
using both A09.9 and K52.9 ICD-10 codes for outcome ascertainment in future rotavirus vaccine impact studies to 
ensure that all unspecified cases of AGE are captured, especially if the study period spans 2009.
Keywords: Acute gastroenteritis, Administrative data, Epidemiology, International Classification of Diseases (ICD), 
Rotavirus vaccine, Vaccine impact
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Background
Rotavirus vaccination is a highly efficacious strategy to 
prevent rotavirus (RV) associated acute gastroenteritis 
(AGE), the most common cause of childhood AGE glob-
ally and an important contributor to childhood morbidity 
and mortality [1]. Two RV vaccines are licensed for use in 
Canada, RotaTeq® (RV5, Merck) since August 2006 and 
Rotarix(™) (RV1, GlaxoSmithKline) as of October 2007. 
Since 2008, RV vaccination has been recommended by 
Canada’s National Advisory Committee on Immuniza-
tion [2, 3]. In August 2011, Ontario (population 13.5 
million) was one of the the first Canadian jurisdiction to 
implement a publicly-funded program, using RV1. RV 
vaccines have since been included within the publicly-
funded routine immunization schedules of nine of Cana-
da’s 13 provinces and territories [4].
Numerous studies, conducted among counties of vary-
ing economic development, have demonstrated a rapid 
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and dramatic impact of RV immunization programs, 
observing a reduction in the number of infants and chil-
dren requiring hospitalization or Emergency Department 
(ED) visits by up to 85  % [5–10]. With few exceptions 
[11], RV infection is not typically a statutory notifiable 
disease and therefore not captured by routine surveil-
lance data. Furthermore, even in countries of high eco-
nomic development, most children with RV infections 
receive syndromic management for AGE with rehydra-
tion without laboratory confirmation [12]. Consequently, 
RV vaccine program impact studies have used a variety 
of study designs to mitigate these challenges, notably the 
use of administrative health services data. Such stud-
ies use a variety of outcome definitions using the World 
Health Organization (WHO)’s International Classifica-
tion of Disease (ICD) diagnostic codes, to examine the 
impact of vaccination on RV-specific AGE and all cause 
AGE (Table 1). Although the positive predictive value is 
consistently high, the sensitivity of the ICD-9 [13, 14] and 
ICD-10 [15] codes for RV AGE (A08.0) is low and studies 
have included additional AGE codes to evaluate program 
impact, including codes which capture other viral, bacte-
rial and parasitic pathogens and unspecified etiologies. 
This strategy helps to mitigate the challenges posed by 
misclassification of true RV infections within other diag-
nostic codes for AGE [13–15]. This misclassification is 
explained in large part by the syndromic management of 
AGE and variability in practice patterns for confirmation 
of RV as a specific causative agent [12].
We undertook a study of early RV vaccine program 
impact on hospitalizations and ED visits for AGE in 
Ontario, Canada using a combination of ICD-10 codes 
similar to the general approach used by Lopman and 
colleagues who used ICD-9 codes in their analyses [16]. 
In Canada, a country-specific modification of ICD-10 is 
used, ICD-10-CA [17]. Our plan was to examine program 
impact using both the code specific to RV AGE (A08.0) 
and a combination of codes capturing AGE, including RV, 
other viral etiologies, and AGE of undetermined infec-
tious etiology, consistent with earlier studies. Early in our 
analysis, we observed an unexpected increase in AGE 
hospitalizations in several pediatric age cohorts begin-
ning in April 2009. The objective of this short report is 
to describe our investigation of this finding, which was 
subsequently attributed to an ICD-10 coding directive 
change for AGE of undetermined etiology.
Findings
Methods
Data were extracted as part of a larger retrospective, lon-
gitudinal population-based cohort study to investigate 
the impact of a publicly-funded routine rotavirus immu-
nization program on AGE among all Ontarians with valid 
provincial health insurance between the period of Janu-
ary 1, 2003 and March 31, 2013. There is no parallel pri-
vate system for accessing health services in Ontario thus, 
all permanent residents in Ontario are covered under 
the provincial health insurance. Demographic data con-
tained within the Registered Persons Database (RPDB) 
facilitated deterministic linkage across administrative 
databases at the individual-level using a unique identifi-
cation number. These datasets were linked using unique 
encoded identifiers and analyzed at the Institute for Clin-
ical Evaluative Sciences (ICES). This study was approved 
by the institutional review board at Sunnybrook Health 
Sciences Centre and Public Health Ontario in Toronto, 
Canada.
Individual AGE hospitalizations were obtained from 
the Discharge Abstract Database (DAD) of the Canadian 
Institutes for Health Information (CIHI) and individual 
ED visits from the National Ambulatory Care Reporting 
System (NACRS). In our original analysis, having any one 
of the following ICD-10-CA codes listed as the diagno-
sis type M, the one diagnosis or condition that can be 
described as being the most responsible for the patient’s 
hospitalization or ED visit, was used for outcome ascer-
tainment of AGE and included: rotaviral enteritis 
(A08.0), other viral gastroenteritis (A08.3), viral intestinal 
infection, unspecified (A08. 4), other specified intestinal 
infections (A08.5), and other gastroenteritis and coli-
tis of infectious and unspecified origin (A09) (definition 
one) (Table 2). The outcome definition was subsequently 
expanded to include noninfective gastroenteritis and 
colitis, unspecified (K52.9) (definition two). As our goal 
was to assess program impact on health service utiliza-
tion rather than to characterize burden of disease, health 
services events, rather than individuals were the unit of 
our analysis and formed the numerator; hospitalizations 
and ED consultations were examined separately. For this 
analysis the annual age-specific population in the RPDB 
was used to calculate rates per 10,000 population. Data 
were extracted and analysed using SAS (Version 9.3).
Results
Figure  1 illustrates the characteristic seasonal varia-
tion of AGE hospitalizations and the rise in AGE among 
children 0 to <24  months of age occurring as of April 
2009 when assessed using definition one (i.e., excluding 
K52.9). The average monthly rate of AGE hospitaliza-
tion using this definition was 0.82 per 10,000 from period 
January 2003 to March 2009, rising to 2.35 over the 
period of April 2009 to March 31, 2013. Similar trends 
were found for AGE ED consultations and when the age 
groups assessed included children 0 to <60 months of age 
for both hospitalizations and ED visits (data not shown). 
The original outcome definition was disaggregated to 
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examine trends by individual ICD-10-CA code. A notable 
rise in events corresponding to the A09 code was noted, 
with no increase observed for any other code within our 
original outcome definition. We discussed these findings 
with several clinical experts who were unable to provide 
a clinical, laboratory or administrative explanation for 
these observations. Australian investigators found an 
increase in stool testing for RV following vaccine pro-
gram implementation [15] and US data suggested a mod-
est short-term increase in number of tests performed in 
some laboratories [18, 19]; however, Ontario’s RV vaccine 
program was implemented in 2011 and the rise clearly 
began in 2009. Furthermore, the increase was specific to 
the A09 code, as opposed to across AGE codes, nor spe-
cific to the RV AGE code. Next, we corresponded with 
CIHI who shared documentation confirming that the 
rise in events corresponding to the ICD-10-CA code of 
A09 was explained by a change in directive for the clas-
sification of unspecified gastroenteritis contained within 
the release of ICD-10-CA Version 2009 which noted 
that “most cases of gastroenteritis are infectious, even 
in industrialized countries, thus the ICD-10-CA version 
2009 classifies gastroenteritis not otherwise specified 
(NOS) as infectious (A09.9)” [20] (Table 2). The directive 
used earlier was deleted which read as follows: “Assume 
gastroenteritis to be noninfectious unless documented as 
infectious by the responsible physician” [20]. The date of 
these changes was April 1, 2009; the document contain-
ing these changes was revised further in September 2009. 
Therefore, cases of AGE previously classified under the 
code K52.9, are now classified under code A09.9 in the 
version of ICD-10 used in Canada (ICD-10-CA). CIHI 
also confirmed that the direction for this change came 
directly from WHO and therefore, applies to ICD-10 and 
all modifications of ICD-10 (i.e. ICD-10-CA).
We explored the coding change within our Ontario 
data, adding K52.9 to our outcome definition. The impact 
of this modification to our outcome definition is pre-
sented in Figs. 1 and 2. Over the period of January 1 2003 
and March 31 2009, the average monthly rate of hospi-
talizations assigned the codes captured under A09 (other 
gastroenteritis and colitis of infectious and unspecified 
origin) among children under 24 months of age was 0.12 
per 10,000 population; in contrast to 1.95 per 10,000 pop-
ulation over the period of April 1 2009 to March 31 2013. 
The average monthly rate for the code K52.9 per 10,000 
Table 1 Examples of rotavirus vaccine impact studies conducted using ICD-10 administrative data
Study (pub year) Country Time period ICD-10 codes used for outcome  
definition (code descriptions  
from WHO [20])
RV-specific AGE (A08.0) 




Australia 2000–2009 A01-A07 [excluding A02.2, A06.4, A06.5, A06.6, A06.7] (AGE of 
bacterial etiology)
A06-A07 (AGE of parasitic etiology)
A08.0 (Rotavirus AGE)
A08.1-A08.4 (Other viral AGE)
A09 (AGE of undetermined etiology, presumed infectious)
K52 (AGE of undetermined etiology, presumed non-infectious)
R198 (Other signs and symptoms involving the digestive system 
and abdomen)
Yes
Leino et al. (2012) [22] Finland 1999–2005,  
2010
A00-A07 (AGE due to bacterial and parasitic etiologies)
A08.0 (Rotavirus AGE)
A08.4 (Other viral AGE)
A09 (AGE of undetermined etiology, presumed infectious)
R11 (nausea and vomiting)
A00.9, A01.4, A02.9, A03.9, A4.9, A05.9, A06.9, A07.9 and A09 (AGE 
of undetermined etiology)
K52 (AGE of undetermined etiology, presumed non-infectious)
Yes




A08 (Rotavirus and other viral AGE)
A09 (AGE of undetermined etiology, presumed infectious)
No
Molto et al. (2011) [23] Panama 2003–2008 A00.0-A05.9 (AGE of bacterial etiology)
A06.0-A07.9 (AGE of parasitic etiology)
A08.0-A08.5 (Rotavirus and other viral AGE)
A09 (AGE of undetermined etiology, presumed infectious)
No
Quintanar-Solares 
et al. (2011) [8]
Mexico Jan. 2003–June 
2009
A00-A003 (Codes capturing cholera)
A04-A05 (AGE of bacterial etiology)
A06.0-A06.3, A06.9 (AGE of parasitic etiologies, e.g. amoebic)
A07.0-A07.2, A07.9 (AGE of parasitic etiologies, e.g. protozoal)
A08 (Rotavirus and other viral AGE)
A09 (AGE of undetermined etiology, presumed infectious)
No
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population was 3.62 before the coding change and 0.09 
following its implementation. Further examination of the 
vaccine’s impact on AGE hospitalizations and ED visits 
in Ontario has since been conducted using the modified 
outcome definition.
Discussion
Many countries have developed clinical modifications 
to ICD-10 in order to address their specific needs and 
a Canadian modification of ICD-10, ICD-10-CA, was 
implemented in 1995 [17]. Through our correspond-
ence with CIHI we confirmed that the change in direc-
tive to code cases of gastroenteritis NOS as infectious, 
as opposed to non-infectious, was made to the ICD-10, 
including the ICD-10-CA in 2009. Online ICD-10 docu-
mentation from WHO for versions prior to 2010 include 
the note that “in countries where any term listed in A09 
without further specification can be assumed to be of 
non-infectious origin, the condition should be classified 
to K52.9”; however, this statement is no longer found in 
the online documentation for the most current version, 
ICD-10 Version 2010 [21]. A small number of countries, 
notably including the United States (US) [22], continue 
to use ICD-9; although the US has used ICD-10 to code 
its mortality data since 1999 [22]. The coding changes 
described here regarding K52.9 in ICD-10 challenged 
the examination of trends in diarrheal deaths, in at least 
one US evaluation [23]. No similar change in directive 
for AGE classification has occurred in ICD-9. Rota-
virus vaccine impact studies have utilized a wide array 
of ICD-10 discharge codes to capture AGE. Some have 
used both K52.9 and A09, while others have used only 
Table 2 ICD-10-CA code definitions and language describing the change in coding directive
ICD-10-CA Code Definition and notes in ICD-10-CA [26]
A08.0 Rotaviral enteritis
A08.3 Other viral gastroenteritis
A08.4 Viral intestinal infection, unspecified
Includes: viral enteritis not otherwise specified (NOS), viral gastroenteritis NOS, and viral gastroenteropathy NOS)
A08.5 Other specified intestinal infections
A09 Other gastroenteritis and colitis of infectious and unspecified origin Excludes: due to bacterial, protozoal, viral and other specified 
infectious agents (A00-A08) and noninfective (see noninfectious) diarrhoea (K52.9)
K52.9 Noninfective gastroenteritis and colitis, unspecified
Includes: diarrhea, enteritis, ileitis, jejunitis, and sigmoiditis if specified as noninfectious
Excludes: colitis, diarrhoea, enteritis, gastroenteritis if coded as infectious (A09.0) or of unspecified origin (A09.9); functional diar-
rhoea (K59.1); neonatal diarrhoea (noninfective) (P78.3); psychogenic diarrhoea (F45.3)
Description of coding directive as described within the 2009 Canadian Coding Standards [27]
Change Rationale
“Deleted the directive: “Assume gastroenteritis to be noninfectious unless 
documented as infectious by the responsible physician””
“Added an introductory sentence: “most cases of gastroenteritis are infec-
tious, even in industrialized countries, thus ICD-10-CA version 2009 clas-
sifies gastroenteritis NOS as infectious (A09.9 Gastroenteritis and colitis of 
unspecified origin)””
“To align with the change for v2009 ICD-10-CA. The code K52.9 Noninfec-




























































































































































AGE Definion 1 (A08.0, A08.3, A08.4, A08.5, A09) AGE Definion 2 (A08.0, A08.3, A08.4, A08.5, A09, K52.9)
Fig. 1 Seasonal variation in hospitalizations for acute gastroenteritis illustrated with two case definitions using ICD-10 diagnostic codes among 
Ontario children 0 to <24 months of age, January 2003 to March 2013
Page 5 of 6Wilson et al. BMC Res Notes  (2015) 8:439 
A09, to capture unspecified AGE (Table 1) [8, 9, 15, 24, 
25]. The code selection for program impact studies is 
informed by various factors including study objectives. 
Future investigators need to be aware of this change in 
direction for AGE classification within ICD-10 when 
establishing their outcome definition. If the study period 
includes 2009, they will need to include both A09 and 
K52.9 to capture AGE of undetermined etiology. Given 
the timing of RV vaccine program introduction, inclu-
sion of this time period is likely in many studies. In our 
impact study, had we excluded K52.9 from our outcome 
definition for AGE, we would have under-estimated 
program impact and instead, paradoxically found evi-
dence of an increased burden of AGE following program 
implementation.
Valid estimates of RV vaccine program impact using 
administrative data are dependent on the comparabil-
ity of hospital discharge coding practices and RV stool 
testing patterns pre- and post- program implementa-
tion. Most validation work of ICD codes for RV AGE 
has been conducted using ICD-9 in the United States, 
prior to program implementation [13, 14]. More recently, 
Jayasinghe and Macartney [15] examined hospitaliza-
tion ICD-10 data and laboratory testing in a large tertiary 
pediatric hospital in Australia pre-and post- vaccine pro-
gram implementation. They found that the sensitivity and 
positive predictive value of the RV-specific code (A08.0) 
had not significantly changed post program implementa-
tion despite evidence of greater RV stool testing following 
the program’s introduction [15]. Studies utilizing admin-
istrative data are important for estimating immunization 
program impact at a population-level; however, there are 
important limitations and other considerations investiga-
tors and knowledge users must be aware of. The coding 
directive implemented in the 2009 Version of ICD-10 is 
an illustrative example.
Conclusions
The change in directive for the classification of unspeci-
fied gastroenteritis which occurred in the 2009 Version 
of ICD-10 is important for investigators planning evalu-
ations of rotavirus immunization programs to be aware 
of. We recommend that researchers consider using both 
A09.9 and K52.9 to ensure that all unspecified cases of 
AGE, both presumed infectious and non-infectious, are 
captured in studies using administrative data, if the study 
period spans 2009.
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April 2009: Change in direcve for 
classificaon of unspecified AGE in the 
2009 Version of the  ICD-10
August 2011: Implementaon of 
Ontario's publicly funded rotavirus 
immunizaon program
Fig. 2 Temporal trends in hospitalizations for acute gastroenteritis, using select ICD-10-CA codes among Ontario children 0 to <24 months of age, 
January 2003 to March 2013
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